Cardiovascular and Thoracic Surgery Department, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Anesthesiology Department, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Eur J Cardiothorac Surg. 2021 May 8;59(5):1069-1076. doi: 10.1093/ejcts/ezaa427.
Our goal was to analyse the influence of preoperative aortic regurgitation (AR) on the necessity of cusp repair during valve-sparing reimplantation (VSR). We focused on patients with tricuspid aortic valves (TAV) and evaluated the impact of AR and cusp repair on long-term outcomes.
From March 1998 to December 2018, a total of 512 consecutive patients underwent VSR at our institution; of these, 303 had a TAV. The mean age was 53 ± 15 years, and the median follow-up was 6.12 years. The rate and type of cusp repair were analysed based on preoperative AR. Time-to-event analysis was performed, as well as risk of death, reoperation and AR recurrence.
Cusp repair was necessary in 168 (55.4%) patients; the rate rose significantly as AR grade increased (P < 0.001). In-hospital mortality was 1% (n = 3). At 5 and 10 years, overall survival was 92 ± 2% and 75 ± 5%, respectively. Freedom from valve reoperation was 95 ± 2% and 90 ± 3%. Freedom from AR >2+ and AR >1+ at 10 years was 88 ± 4% and 70.4 ± 4.6%, respectively. Independent predictors of death included age, New York Heart Association functional class and type-A aortic dissection. Predictors of AR greater than mild included previous cardiac surgery and severe preoperative AR.
In patients with TAV receiving VSR, the necessity of cusp repair increased with the degree of preoperative AR. Preoperative AR and cusp repair do not impact long-term survival and aortic valve reoperation, but severe preoperative AR and multiple cusp repair increase the risk of recurrent moderate-to-severe AR. Overall, cusp repair seems to attenuate the negative impact of preoperative AR for at least 1 decade in a majority of patients.
本研究旨在分析术前主动脉瓣反流(AR)对保留瓣膜主动脉根部替换术(VSR)中瓣叶修复必要性的影响。研究对象为三尖瓣主动脉瓣(TAV)患者,评估 AR 及瓣叶修复对长期预后的影响。
1998 年 3 月至 2018 年 12 月,共有 512 例患者在我院行 VSR,其中 303 例为 TAV。患者平均年龄为 53±15 岁,中位随访时间为 6.12 年。根据术前 AR 分析瓣叶修复的类型和必要性。进行生存时间分析,评估死亡率、再次手术率和 AR 复发率。
168 例(55.4%)患者需要行瓣叶修复,且随着 AR 分级的增加,瓣叶修复率显著升高(P<0.001)。院内死亡率为 1%(n=3)。5 年和 10 年总生存率分别为 92±2%和 75±5%。无瓣膜再次手术率分别为 95±2%和 90±3%。10 年时 AR>2+和 AR>1+的无复发率分别为 88±4%和 70.4±4.6%。死亡的独立预测因素包括年龄、纽约心脏协会心功能分级和 A 型主动脉夹层。AR 大于轻度的独立预测因素包括既往心脏手术和术前严重 AR。
在接受 VSR 的 TAV 患者中,术前 AR 程度与瓣叶修复的必要性呈正相关。术前 AR 和瓣叶修复不影响长期生存率和主动脉瓣再次手术率,但术前 AR 严重和多处瓣叶修复会增加中重度 AR 复发的风险。总的来说,在大多数患者中,瓣叶修复至少在 10 年内减轻了术前 AR 的负面影响。